The International Basketball Federation (FIBA) has reported an anti-doping rule violation against the Player after his sample tested positive for the prohibited substance hydromorphone.
After notification the Player filed a statement and evidence in his defence and was heard for the FIBA Disciplinary Panel.
The Player stated he suffers from RTC syndrome in both his shoulders since the summer of 2009 which occasionally causes him sharp pain. Therefore his family doctor prescribed him the medication Acetimophen with Hydrocodone (hydromorphone) for the pain. His doctor confirmed having prescribed the medication to the Player.
The Player argued he used the medication shortly before the game and stated that the Acetimophen with Hydrocodone must have been the source of the prohibited substance.
The Panel accepts Player’s statement and finds Player’s negligence truly insignificant. Therefore the FIBA Disciplinary Panel decides a 1 month period of ineligibility.
FIBA 2010 FIBA vs Vernard Hollins
Original document
Parameters
- Legal Source
- Decisions International Federations
- Date
- 20 September 2010
- Arbitrator
- Günter, Heinz
- Mizzi, Antonio
- Original Source
- International Basketball Federation (FIBA)
- Country
- United States of America
- Language
- English
- ADRV
- Adverse Analytical Finding / presence
- Legal Terms
- No Significant Fault or Negligence
- Period of ineligibility
- Sport/IFs
- Basketball (FIBA) - International Basketball Federation
- Laboratories
- Lausanne, Switzerland: Laboratoire Suisse d’Analyse du Dopage
- Doping classes
- S7. Narcotics
- Substances
- Hydromorphone
- Medical terms
- Legitimate Medical Treatment
- Document type
- Pdf file
- Date generated
- 11 September 2013
- Date of last modification
- 27 February 2014